vs
Astrana Health, Inc.（ASTH）与SLM Corp（SLM）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是SLM Corp的1.7倍（$950.5M vs $560.0M），SLM Corp净利率更高（55.0% vs 0.7%，领先54.3%），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 22.7%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
尼康旗下SLM Solutions AG总部位于德国吕贝克，是金属3D打印机领域的上市生产商，共同拥有SLM文字商标，集团股份自2014年5月9日起在法兰克福证券交易所高级市场板块挂牌交易。
ASTH vs SLM — 直观对比
营收规模更大
ASTH
是对方的1.7倍
$560.0M
净利率更高
SLM
高出54.3%
0.7%
两年增速更快
ASTH
近两年复合增速
22.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $560.0M |
| 净利润 | $6.6M | $308.0M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | — |
| 净利率 | 0.7% | 55.0% |
| 营收同比 | 42.9% | — |
| 净利润同比 | 184.4% | 1.0% |
| 每股收益（稀释后） | $0.12 | $1.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHSLM
| Q1 26 | — | $560.0M | ||
| Q4 25 | $950.5M | $377.1M | ||
| Q3 25 | $956.0M | $373.0M | ||
| Q2 25 | $654.8M | $376.8M | ||
| Q1 25 | $620.4M | $375.0M | ||
| Q4 24 | $665.2M | $362.2M | ||
| Q3 24 | $478.7M | $359.4M | ||
| Q2 24 | $486.3M | $372.2M |
净利润ASTHSLM
| Q1 26 | — | $308.0M | ||
| Q4 25 | $6.6M | $233.2M | ||
| Q3 25 | $373.0K | $135.8M | ||
| Q2 25 | $9.4M | $71.3M | ||
| Q1 25 | $6.7M | $304.5M | ||
| Q4 24 | $-7.8M | $111.6M | ||
| Q3 24 | $16.1M | $-45.2M | ||
| Q2 24 | $19.2M | $252.0M |
营业利润率ASTHSLM
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 83.8% | ||
| Q3 25 | 2.0% | 49.8% | ||
| Q2 25 | 3.1% | 23.3% | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.1% | 36.5% | ||
| Q3 24 | 5.9% | -16.6% | ||
| Q2 24 | 6.2% | 91.0% |
净利率ASTHSLM
| Q1 26 | — | 55.0% | ||
| Q4 25 | 0.7% | 61.8% | ||
| Q3 25 | 0.0% | 36.4% | ||
| Q2 25 | 1.4% | 18.9% | ||
| Q1 25 | 1.1% | 81.2% | ||
| Q4 24 | -1.2% | 30.8% | ||
| Q3 24 | 3.4% | -12.6% | ||
| Q2 24 | 3.9% | 67.7% |
每股收益（稀释后）ASTHSLM
| Q1 26 | — | $1.54 | ||
| Q4 25 | $0.12 | $1.11 | ||
| Q3 25 | $0.01 | $0.63 | ||
| Q2 25 | $0.19 | $0.32 | ||
| Q1 25 | $0.14 | $1.40 | ||
| Q4 24 | $-0.14 | $0.53 | ||
| Q3 24 | $0.33 | $-0.23 | ||
| Q2 24 | $0.40 | $1.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $5.2B |
| 总债务越低越好 | — | $6.2B |
| 股东权益账面价值 | $779.3M | $2.4B |
| 总资产 | $2.2B | $29.4B |
| 负债/权益比越低杠杆越低 | — | 2.53× |
8季度趋势，按日历期对齐
现金及短期投资ASTHSLM
| Q1 26 | — | $5.2B | ||
| Q4 25 | $429.5M | $4.2B | ||
| Q3 25 | $463.4M | $3.5B | ||
| Q2 25 | $342.1M | $4.1B | ||
| Q1 25 | $260.9M | $3.7B | ||
| Q4 24 | $290.8M | $4.7B | ||
| Q3 24 | $350.3M | $4.5B | ||
| Q2 24 | $327.7M | $5.3B |
总债务ASTHSLM
| Q1 26 | — | $6.2B | ||
| Q4 25 | — | $5.4B | ||
| Q3 25 | — | $6.8B | ||
| Q2 25 | — | $6.4B | ||
| Q1 25 | — | $6.1B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | — | $6.0B | ||
| Q2 24 | — | $5.4B |
股东权益ASTHSLM
| Q1 26 | — | $2.4B | ||
| Q4 25 | $779.3M | $2.5B | ||
| Q3 25 | $775.5M | $2.3B | ||
| Q2 25 | $765.5M | $2.4B | ||
| Q1 25 | $745.4M | $2.4B | ||
| Q4 24 | $712.7M | $2.2B | ||
| Q3 24 | $704.6M | $2.1B | ||
| Q2 24 | $678.9M | $2.3B |
总资产ASTHSLM
| Q1 26 | — | $29.4B | ||
| Q4 25 | $2.2B | $29.7B | ||
| Q3 25 | $2.2B | $29.6B | ||
| Q2 25 | $1.4B | $29.6B | ||
| Q1 25 | $1.3B | $28.9B | ||
| Q4 24 | $1.4B | $30.1B | ||
| Q3 24 | $1.3B | $30.0B | ||
| Q2 24 | $1.3B | $28.8B |
负债/权益比ASTHSLM
| Q1 26 | — | 2.53× | ||
| Q4 25 | — | 2.19× | ||
| Q3 25 | — | 2.92× | ||
| Q2 25 | — | 2.70× | ||
| Q1 25 | — | 2.56× | ||
| Q4 24 | — | 2.98× | ||
| Q3 24 | — | 2.83× | ||
| Q2 24 | — | 2.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | — |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHSLM
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $-64.5M | ||
| Q3 25 | $10.0M | $-49.3M | ||
| Q2 25 | $90.9M | $-138.7M | ||
| Q1 25 | $16.6M | $-146.1M | ||
| Q4 24 | $-10.9M | $4.5M | ||
| Q3 24 | $34.0M | $-113.4M | ||
| Q2 24 | $23.2M | $-143.8M |
自由现金流ASTHSLM
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — |
自由现金流率ASTHSLM
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — |
资本支出强度ASTHSLM
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — |
现金转化率ASTHSLM
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | -0.28× | ||
| Q3 25 | 26.69× | -0.36× | ||
| Q2 25 | 9.65× | -1.95× | ||
| Q1 25 | 2.48× | -0.48× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | -0.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SLM
| Net Interest Income | $375.0M | 67% |
| Noninterest Income | $185.0M | 33% |
